Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy - sprookjes - yvandenbroek - TriplyDB

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

http://www.wikidata.org/entity/Q27002646

about

Oncolytic viruses as immunotherapy: progress and remaining challenges Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus Immune cell interplay in colorectal cancer prognosis Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity Trial Watch:: Oncolytic viruses for cancer therapy The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention Boolean immunotherapy: reversal of fortune.Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine Melanoma.Moonshots and metastatic disease: the need for a multi-faceted approach when studying atypical responses.Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.Oncogene withdrawal engages the immune system to induce sustained cancer regression.An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.Enhancement of T cell recruitment and infiltration into tumours.Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors.Glioma-derived ADAM10 induces regulatory B cells to suppress CD8+ T cells.The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy.Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer.Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome.Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment.Rise of iPSCs as a cell source for adoptive immunotherapy.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.The role of oncolytic virus immunotherapies to subvert cancer immune evasion.Oncolytic virus immunotherapy for melanoma.Arming oncolytic viruses to leverage antitumor immunity.Immunotherapy and tumor microenvironment Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model.Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers.ΔPK oncolytic activity includes modulation of the tumour cell milieu.The oncolytic virus ΔPK has multimodal anti-tumor activity.Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma.The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma.A Primer for Oncoimmunology (Immunooncology).Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells.Reactivity of the immunological system of rats stimulated with Biolex-Beta HP after cyclophosphamide immunosuppression.Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy.IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killing Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

P2860

Q26745942-0B68FC6C-2A3F-4764-B958-603CD8192198 Q26771799-DE657663-168D-4995-AABB-76D99862A7E3 Q26781453-57402B93-B3C2-450A-89E2-54246166F5A6 Q26992272-B8DA23A0-15B8-4D4B-9121-1971231E967D Q27021951-7FF566BE-5514-4EB5-8E8E-B13805CA4EBC Q27024781-08BCD73A-9485-43EA-8475-93A1A4F0578B Q33724290-663CB9ED-952E-49EE-A65B-6C4EF40F0D0D Q33741348-29044776-E7DD-4E95-B391-C5C687134D11 Q33767521-FA7A9593-97A1-4692-9501-2552F8AFA1AB Q33771631-CB280EF0-15E6-45E3-B726-B8136E7C8680 Q33987633-16FAC4E3-E677-4DEB-A9A2-ACE727D54401 Q34361976-92233A7D-9786-4BA3-B58E-46E9683313C1 Q35178939-04F90D58-650F-4DF0-B4D3-4E25F68A1A32 Q35201835-88C26450-B6A4-46C0-8EAF-E54D43B9A867 Q35225653-F6D6352D-49F1-4FB4-85D5-A21F8A31C27F Q35547103-87647421-325E-4708-9474-CC08A1ED34EF Q35999941-A0FA0449-80EE-48FF-B022-A0E983D1F126 Q36664213-37071B5A-1D67-4463-B28C-C1E1AF624D93 Q37225198-0D1AFB08-F636-4E3F-9321-B720C7D8857D Q37557707-BC3C519A-5EC1-4DE3-90B1-E3CE0E17CDB6 Q37670024-698AD4D5-9E11-4FFE-B79E-D911E5F047BF Q37731681-60D31EDE-24F9-4F44-A083-1F5D6CA7C66F Q38186628-33F13226-324D-4587-BFBB-93C37A2B5BC7 Q38223419-1A15F05D-F814-45DF-8FA0-C303ED63B635 Q38357137-1B6E387B-3E16-41BB-9FF9-628ED7883813 Q38380394-36ABD62E-6F1F-436F-86CF-A4DE2786BCD1 Q38470166-9D923106-86B1-42EE-87E8-E01A41CC7D90 Q38610306-6173A2B9-4567-4064-9874-D4153739484B Q38765125-D7384172-BD56-40AF-92CA-0A9A324E5178 Q38806038-8164EC4B-38B5-498E-BD6B-BEDB1454FAC3 Q38817112-9EDA6741-B58F-4460-8CDB-764B5B75DD7F Q38848885-815E9EC3-C86F-4FF8-B484-74F7F34A01BC Q38878893-3E844570-D96D-4272-84E2-8AAC6A1AF89D Q39012765-760B262D-4509-4DA7-9DF0-CDFB40DCE80D Q39387761-D34233CF-52ED-4F95-8010-3CD3C617D4D0 Q40074591-04DA202B-BD3A-4F0F-8B71-1B661FB0F754 Q40924134-F0F977E3-FA4F-4350-AD2B-8C977E4873F7 Q40982444-FDD60500-1EA0-49EA-9EC7-D26CAF44B2C8 Q40987686-50906E48-94D1-4749-BCAC-BE9866608954 Q41876229-BDCB88CE-93E0-4EB7-A7C3-E04D6E67D2DF

P2860

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

http://www.wikidata.org/entity/Q27002646

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

@ast

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

@en

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

@nl

type

label

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

@ast

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

@en

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

@nl

prefLabel

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

@ast

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

@en

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

@nl

P1433

Q27002646-BE8B51AE-88D6-4464-AF98-2CE7DFEA72D7

P1476

Q27002646-FCF22CDB-C78F-4C91-9C52-2A7727FE5F03

P2093

Q27002646-3A3D8B1B-AFF3-4DD7-A5F6-47E7360B4414

Q27002646-B3DCEFF4-07AE-49BE-89BA-2322D76594CC

Q27002646-D06EF219-E5EC-41B6-8FB8-C2E928DBB414

P2860

Q27002646-00CA1A2A-252F-4FC8-8DEF-87E265084246

Q27002646-017C5DC0-2957-4BB4-8E38-A94E6869852D

Q27002646-01A281B2-E5C5-44EA-86D8-77267D33CB2A

Q27002646-029CD6EE-6C87-4CA2-932F-00B3DAC1F616

Q27002646-04C46822-3D8C-4F9A-AE21-4AF5486812D3

Q27002646-05950FA3-0BF8-4FC8-864A-1ED5B63BF8C9

Q27002646-07729DC4-34A0-4D88-A4C4-A80E09DD1720

Q27002646-0A00E68D-CD95-46E8-8065-47CC0814607A

Q27002646-0B0BE743-1D6E-429A-84EC-BDB5EBA511EC

Q27002646-0B818317-3345-4DB9-BFFE-9CA89A065C40

P304

Q27002646-BE1D17DD-5FEA-488A-B611-CB4DFDC5C458

P31

Q27002646-AF7CAB89-B77D-4685-A37C-0EBEE702D2A5

P3181

Q27002646-70E37B4D-F961-483F-9373-9A7460B75212

P356

Q27002646-596FEA27-B4D2-492C-82EE-108839B84D23

P433

Q27002646-288F7B77-66B9-4115-A5BB-707906133887

P478

Q27002646-47C58479-60C8-4213-8C58-C7AFD5884B90

P50

Q27002646-984E4AA7-36AE-44EF-8C98-857D8C0C1811

Q27002646-D3226A6E-DEB8-49E7-9BC9-89AC14311C45

P577

Q27002646-7AB5BD1F-1D03-40C9-9C3D-59F4D4F561B4

P5875

Q27002646-A454E95D-495A-4F00-B0C7-F8FC6297C5B9

P698

Q27002646-CD23F1F4-76E9-4DE8-AEDD-BA946D1CBEE6

P921

Q27002646-13CD991B-BF17-4BC3-A452-CB4FDBBF88FB

P932

Q27002646-59DBDEDB-94FE-4B96-9D0C-731BC34CDCEA

P3181

P356

P1433

P1476

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

@en

P2093

Christel Devaud

http://www.w3.org/2001/XMLSchema#string

Jennifer A Westwood

http://www.w3.org/2001/XMLSchema#string

Liza B John

http://www.w3.org/2001/XMLSchema#string

P2860

TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Nivolumab plus ipilimumab in advanced melanoma.

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Myeloid-derived suppressor cells as regulators of the immune system

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

Myeloid suppressor cell depletion augments antitumor activity in lung cancer

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

P304

e25961

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1851433

http://www.w3.org/2001/XMLSchema#string

P356

10.4161/ONCI.25961

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Michael H. Kershaw

Phillip K. Darcy

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257251374

http://www.w3.org/2001/XMLSchema#string

P698

24083084

http://www.w3.org/2001/XMLSchema#string

P921

P932

3782527

http://www.w3.org/2001/XMLSchema#string